PTC Therapeutics, Cantor Fitzgerald
Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.
The stock's fall snapped a two-day winning streak.
Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...
The U.S. Department of the Treasury and IRS on Jan. 10, 2025, released initial guidance regarding the production tax credit (PTC) for clean ...
Shares of PTC Inc. PTC advanced 1.30% to $190.93 Tuesday, on what proved to be an all-around great trading session for the ...
Loop Capital Markets analyst Yun Kim maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $240.00. The ...
Check the time stamp on this data. Updated AI-Generated Signals for Ptc Inc. (PTC) available here: PTC. Type a few symbols ...
Over the past month, PTC Inc. PTC stock increased by 5.53%, and in the past year, by 8.06%. With performance like this, ...
One of the top advanced manufacturing and material technology companies, PTC Industries, has inked a Memorandum of ...
Stampede was not a very big incident; the tragedy is being exaggerated,' says BJP MP and veteran actress Hema Malini ...